1. home
  2. > covid-19
  3. > FDA's emergency approval for antibody therapy given to Trump for Covid
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

FDA's emergency approval for antibody therapy given to Trump for Covid

Nov 22, 2020 09:32 IST

The Food and Drug Administration on Saturday granted an emergency use authorization for Regeneron’s Covid-19 antibody treatment, the experimental therapy given to President Donald Trump when he contracted the coronavirus in October. Regeneron had submitted an emergency use application after preclinical studies showed that the therapy, called REGN-COV2, reduced the amount of virus and associated damage in the lungs of non-human primates. The company said trial data also shows the drug reduces medical visits in patients with mild-to-moderate Covid-19. ‘Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on health care system,” said FDA Commissioner Stephen M. Hahn.

Covid-19